Widespread use of maternal RSV vaccination and nirsevimab during the 2024–2025 U.S. RSV season led to a significant reduction ...

OSA is more likely in children who have LRTIs, and this association contributes to hospitalizations and tonsil and adenoid removal surgeries.

Illness severity of preschoolers presenting to the ED for severe wheezing did not differ between 5-day azithromycin and ...

Agencies working under Robert F. Kennedy Jr. are changing the nation's decades-old system for approving vaccines. The shift ...

Highlights Walking pneumonia is a milder form of regular pneumonia. It can be contagious when caused by specific bacteria or ...

Two preventive tools — a maternal vaccine and a monoclonal antibody — were tied to a recent drop in RSV hospitalization rates for U.S. babies.

Nirsevimab is effective for reducing the burden of respiratory syncytial virus (RSV) in infants in real-world settings.

Recent findings of the impact of new RSV prevention products aimed at protecting babies were published in the Morbidity and Mortality Weekly Report, an epidemiological digest prepared by the Centers ...

New findings provide compelling evidence for the protective benefits of maternal RSVpreF vaccination during pregnancy.

Maternal RSV vaccination and nirsevimab were associated with a reduction in hospitalization rates among infants aged 0 to 7 months.

Maternal RSV vaccination and nirsevimab were associated with a reduction in RSV hospitalization rates in infants aged 0 to 7 months during the 2024-2025 RSV season.

A mum has spoken of the terrifying moment her five-week-old daughter stopped breathing - and thanked the emergency crew who ...